摘要
目的探讨脉搏分析连续心排血量(pulse-indicated continuous cardiac output,Pi CC)在心源性休克患者中应用价值。方法选择2014年3月到2015年3月深圳市南山区人民医院诊治的50例心源性休克患者为研究对象,对其进行PiCCO血流动力学检测,记录相关的参数。再根据患者的存活情况,将其分为死亡组(23例)和存活组(27例),比较两组各个参数,分析其对预后的预测作用。结果两组治疗前和治疗48 h后血流动力学参数比较,存活组的心指数(cardiac index,CI)、全心射血分数(global ejection fraction,GEF)均高于死亡组,而血管外肺水指数(extravascular lung water index,EVLWI)、系统血管阻力指数(systemic vascular resistance in-dex,SVRI)却较死亡组低一些,差异具有统计学意义(P<0.05);两组全心舒张末期容积指数比较,差异无统计学意义(P>0.05)。CI和EVLWI是影响心源性休克患者预后的独立预测因素。结论 PiCCO在心源性休克患者治疗中有着极高的应用价值,医生可以通过对相关指数的监测为患者实施相应的治疗方案,以此达到在后续治疗中预后的目的。
Objectives To investigate the application value on cardiac shock patients by pulse-indicated continuous cardiac output（PiCCO）. Methods Totally 50 patients with cardiac shock from March 2014 to March 2015 in Nan-shan People′s Hospital were selected as research objects. PiCCO hemodynamic testing was carried out and the relevant parameters were recorded. According to the conditations of survival patients （survival group）,the 50 patients were divided into death group（23 cases）and survival group（27 cases）. Parameters were compared between the two groups to predict prognosis. Results Compared the hemodynamic parameters of the two groups after treatment for 48 h,lower cardiac index（CI）,global ejection fraction（GEF）were significantly higher in survival group than in death group ,but extravascular lung water index（EVLWI）,systemic vascular resistance index（SVRI）were significantly ,and the differ-ences were statistically significant（P〈0.05）. Difference of global end-diastolic volumn index between the two groups was not statistically significant （P〉 0.05）. CI and EVLWI were independent predictors of prognosis in patients with cardiac shock. Conclusions PiCCO in patients with cardiac shock has a very high value in the application. The doc-tors can monitor the relevant indicators for the implementation of appropriate treatment for patients in order to achieve the purpose of follow-up treatment in the prognosis.
出处
《岭南心血管病杂志》
2017年第5期606-609,共4页
South China Journal of Cardiovascular Diseases
